Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/22459264
Conclusion of this study
In conclusion, treatment with EGb 761(®) at a once-daily dose of 240 mg was safe and resulted in a significant and clinically relevant improvement in cognition, psychopathology, functional measures and quality of life of patients and caregivers.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study